Bio-Rad Laboratories Current Ratio 2006-2020 | BIO

Current and historical current ratio for Bio-Rad Laboratories (BIO) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Rad Laboratories current ratio for the three months ending March 31, 2020 was 2.40.
Bio-Rad Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $2.08B $0.87B 2.40
2019-12-31 $2.18B $0.91B 2.41
2019-09-30 $2.05B $0.43B 4.72
2019-06-30 $2.09B $0.45B 4.68
2019-03-31 $2.03B $0.44B 4.57
2018-12-31 $2.02B $0.45B 4.49
2018-09-30 $2.03B $0.45B 4.49
2018-06-30 $1.99B $0.44B 4.50
2018-03-31 $1.98B $0.46B 4.33
2017-12-31 $1.98B $0.50B 3.93
2017-09-30 $1.89B $0.47B 4.06
2017-06-30 $1.83B $0.46B 4.01
2017-03-31 $1.73B $0.41B 4.25
2016-12-31 $1.85B $0.47B 3.91
2016-09-30 $1.85B $0.44B 4.18
2016-06-30 $1.81B $0.41B 4.40
2016-03-31 $1.78B $0.40B 4.43
2015-12-31 $1.78B $0.44B 4.03
2015-09-30 $1.79B $0.44B 4.12
2015-06-30 $1.74B $0.40B 4.31
2015-03-31 $1.70B $0.42B 4.08
2014-12-31 $1.72B $0.45B 3.84
2014-09-30 $1.76B $0.50B 3.50
2014-06-30 $1.77B $0.48B 3.68
2014-03-31 $1.77B $0.48B 3.67
2013-12-31 $1.76B $0.49B 3.61
2013-09-30 $1.68B $0.46B 3.62
2013-06-30 $1.90B $0.43B 4.41
2013-03-31 $1.87B $0.45B 4.18
2012-12-31 $1.94B $0.47B 4.10
2012-09-30 $1.85B $0.43B 4.26
2012-06-30 $1.81B $0.42B 4.34
2012-03-31 $1.82B $0.44B 4.09
2011-12-31 $1.80B $0.46B 3.92
2011-09-30 $1.88B $0.42B 4.52
2011-06-30 $1.89B $0.44B 4.27
2011-03-31 $1.80B $0.43B 4.20
2010-12-31 $1.98B $0.67B 2.96
2010-09-30 $1.65B $0.41B 4.02
2010-06-30 $1.56B $0.39B 3.99
2010-03-31 $1.54B $0.40B 3.88
2009-12-31 $1.56B $0.42B 3.72
2009-09-30 $1.50B $0.42B 3.62
2009-06-30 $1.40B $0.38B 3.64
2009-03-31 $1.05B $0.36B 2.95
2008-12-31 $1.09B $0.42B 2.62
2008-09-30 $1.08B $0.39B 2.81
2008-06-30 $1.12B $0.41B 2.74
2008-03-31 $1.05B $0.39B 2.71
2007-12-31 $1.03B $0.41B 2.48
2007-09-30 $1.22B $0.29B 4.26
2007-06-30 $1.17B $0.28B 4.14
2007-03-31 $1.13B $0.27B 4.15
2006-12-31 $1.13B $0.32B 3.54
2006-09-30 $1.09B $0.28B 3.88
2006-06-30 $1.06B $0.28B 3.77
2006-03-31 $0.99B $0.26B 3.83
2005-12-31 $1.01B $0.32B 3.16
2005-09-30 $0.95B $0.30B 3.18
2005-06-30 $0.92B $0.29B 3.15
2005-03-31 $0.92B $0.30B 3.09
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.007B $2.312B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $161.796B 28.06
Medtronic (MDT) Ireland $126.941B 20.64
Stryker (SYK) United States $69.021B 22.40
Boston Scientific (BSX) United States $50.251B 23.63
Baxter (BAX) United States $44.091B 26.91
Lonza Group Ag (LZAGY) Switzerland $37.041B 0.00
Terumo (TRUMY) Japan $28.057B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $26.322B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.470B 16.03
ResMed (RMD) United States $23.342B 36.84
Smith & Nephew SNATS (SNN) United Kingdom $17.880B 0.00
Sunny Optical Technology (SNPTF) China $15.213B 0.00
Insulet (PODD) United States $12.117B 1200.50
DiaSorin S.p.A (DSRLF) Italy $10.937B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $7.417B 0.00
Perrigo (PRGO) Ireland $7.399B 13.24
Quidel (QDEL) United States $7.286B 57.26
Canopy Growth (CGC) Canada $6.813B 0.00
Hill-Rom Holdings (HRC) United States $6.659B 18.77
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
William Demant Holdings (WILYY) Denmark $6.417B 0.00
Haemonetics (HAE) United States $5.439B 32.67
ICU Medical (ICUI) United States $3.980B 29.03
GW Pharmaceuticals (GWPH) United Kingdom $3.925B 0.00
Agios Pharmaceuticals (AGIO) United States $3.636B 0.00
Neogen (NEOG) United States $3.523B 59.67
NuVasive (NUVA) United States $3.220B 25.86
Envista Holdings (NVST) United States $3.020B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.826B 0.00
TG Therapeutics (TGTX) United States $2.406B 0.00
National Vision Holdings (EYE) United States $2.037B 35.24
AtriCure (ATRC) United States $1.994B 0.00
Aurora Cannabis (ACB) Canada $1.624B 0.00
Cardiovascular Systems (CSII) United States $1.306B 0.00
MacroGenics (MGNX) United States $1.247B 0.00
NanoString Technologies (NSTG) United States $1.173B 0.00
Aphria (APHA) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $1.001B 19.96
Cerus (CERS) United States $0.971B 0.00
OraSure Technologies (OSUR) United States $0.923B 185.88
InMode (INMD) Israel $0.838B 17.70
Omeros (OMER) United States $0.837B 0.00
PetIQ (PETQ) United States $0.818B 23.62
DFB Healthcare Acquisitions (AHCO) United States $0.756B 128.08
Eagle Pharmaceuticals (EGRX) United States $0.726B 52.03
VAREX IMAGING (VREX) United States $0.684B 16.99
Quanterix (QTRX) United States $0.681B 0.00
Meridian Bioscience (VIVO) United States $0.635B 23.92
Zynex (ZYXI) United States $0.631B 63.33
Vapotherm (VAPO) United States $0.557B 0.00
Surmodics (SRDX) United States $0.505B 60.88
Lantheus Holdings (LNTH) United States $0.505B 10.16
LeMaitre Vascular (LMAT) United States $0.503B 28.67
Owens & Minor (OMI) United States $0.463B 12.25
Repro-Med Systems (KRMD) United States $0.387B 325.00
Cytosorbents (CTSO) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.333B 24.16
BioLife Solutions (BLFS) United States $0.328B 145.91
Viemed Healthcare (VMD) United States $0.323B 28.90
Neptune Wellness Solutions (NEPT) Canada $0.290B 0.00
Organigram Holdings (OGI) Canada $0.290B 0.00
HEXO (HEXO) $0.256B 0.00
Female Health (VERU) United States $0.241B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Chembio Diagnostics (CEMI) United States $0.191B 0.00
Exagen (XGN) United States $0.175B 0.00
Bovie Medical (APYX) United States $0.157B 0.00
Evolus (EOLS) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Fonar (FONR) United States $0.148B 13.08
Rockwell Medical (RMTI) United States $0.146B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
MTech Acquisition (KERN) United States $0.119B 0.00
Brainsway (BWAY) Israel $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.077B 0.00
Capricor Therapeutics (CAPR) United States $0.077B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
Nephros (NEPH) United States $0.070B 0.00
United-Guardian (UG) United States $0.069B 16.01
GUARDION HEALTH (GHSI) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Senestech (SNES) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00